These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 29808692)

  • 1. [Urinary MicroRNAs as Potential Biomarkers of Bladder Cancer].
    Juráček J; Staník M; Peltanová B; Adamcová S; Doležel J; Fedorko M; Radová L; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):155-157. PubMed ID: 29808692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genome-wide identification of urinary cell-free microRNAs for non-invasive detection of bladder cancer.
    Juracek J; Peltanova B; Dolezel J; Fedorko M; Pacik D; Radova L; Vesela P; Svoboda M; Slaby O; Stanik M
    J Cell Mol Med; 2018 Mar; 22(3):2033-2038. PubMed ID: 29363887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection.
    Pospisilova S; Pazourkova E; Horinek A; Brisuda A; Svobodova I; Soukup V; Hrbacek J; Capoun O; Hanus T; Mares J; Korabecna M; Babjuk M
    Neoplasma; 2016; 63(5):799-808. PubMed ID: 27468885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [MicroRNAs in Prediction of Response to Radiotherapy in Head and Neck Cancer Patients - Pilot Study].
    Ahmad P; Slavík M; Šána J; Hermanová M; Šlampa P; Smilek P; Kazda T; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):137-139. PubMed ID: 29808687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot Study on MicroRNAs as Biomarkers of Response to Sunitinib Treatment in Patients with Metastatic Renall Cell Carcinoma].
    Kováčová J; Juráček J; Poprach A; Büchler T; Kopecký J; Fiala O; Svoboda M; Lojová M; Slabý O
    Klin Onkol; 2018; 31(Supplementum1):161-162. PubMed ID: 29808694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A microRNA biomarker panel for the non-invasive detection of bladder cancer.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie DJ; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Dec; 7(52):86290-86299. PubMed ID: 27863434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Usage of Cerebrospinal Fluid for microRNA Analysis].
    Kopková A; Šána J; Večeřa M; Knoflíčková D; Smrčka M; Slabý O; Fadrus P
    Klin Onkol; 2018; 31(Supplementum1):158-160. PubMed ID: 29808693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of microRNAs in blood and urine as tumour markers for the detection of urinary bladder cancer.
    Tölle A; Jung M; Rabenhorst S; Kilic E; Jung K; Weikert S
    Oncol Rep; 2013 Oct; 30(4):1949-56. PubMed ID: 23877086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using microRNA profiling in urine samples to develop a non-invasive test for bladder cancer.
    Mengual L; Lozano JJ; Ingelmo-Torres M; Gazquez C; Ribal MJ; Alcaraz A
    Int J Cancer; 2013 Dec; 133(11):2631-41. PubMed ID: 23686449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs in tumor samples and urinary extracellular vesicles as a putative diagnostic tool for muscle-invasive bladder cancer.
    Baumgart S; Meschkat P; Edelmann P; Heinzelmann J; Pryalukhin A; Bohle R; Heinzelbecker J; Stöckle M; Junker K
    J Cancer Res Clin Oncol; 2019 Nov; 145(11):2725-2736. PubMed ID: 31552489
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of microRNAs in the urine of patients with bladder cancer.
    Wang G; Chan ES; Kwan BC; Li PK; Yip SK; Szeto CC; Ng CF
    Clin Genitourin Cancer; 2012 Jun; 10(2):106-13. PubMed ID: 22386240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A urinary microRNA (miR) signature for diagnosis of bladder cancer.
    Hofbauer SL; de Martino M; Lucca I; Haitel A; Susani M; Shariat SF; Klatte T
    Urol Oncol; 2018 Dec; 36(12):531.e1-531.e8. PubMed ID: 30322728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation of a panel of microRNA genes is a novel biomarker for detection of bladder cancer.
    Shimizu T; Suzuki H; Nojima M; Kitamura H; Yamamoto E; Maruyama R; Ashida M; Hatahira T; Kai M; Masumori N; Tokino T; Imai K; Tsukamoto T; Toyota M
    Eur Urol; 2013 Jun; 63(6):1091-100. PubMed ID: 23200812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary extracellular vesicles-encapsulated miRNA signatures: A new paradigm for urinary bladder cancer diagnosis and classification.
    Kural S; Jain G; Agarwal S; Das P; Kumar L
    Urol Oncol; 2024 Jul; 42(7):179-190. PubMed ID: 38594151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary cell-free microRNA-106b as a novel biomarker for detection of bladder cancer.
    Zhou X; Zhang X; Yang Y; Li Z; Du L; Dong Z; Qu A; Jiang X; Li P; Wang C
    Med Oncol; 2014 Oct; 31(10):197. PubMed ID: 25168920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary MicroRNAs as Potential Markers for Non-Invasive Diagnosis of Bladder Cancer.
    Erdmann K; Salomo K; Klimova A; Heberling U; Lohse-Fischer A; Fuehrer R; Thomas C; Roeder I; Froehner M; Wirth MP; Fuessel S
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32471285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-21-5p, miR-141-3p, and miR-205-5p levels in urine-promising biomarkers for the identification of prostate and bladder cancer.
    Ghorbanmehr N; Gharbi S; Korsching E; Tavallaei M; Einollahi B; Mowla SJ
    Prostate; 2019 Jan; 79(1):88-95. PubMed ID: 30194772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A panel of eight-miRNA signature as a potential biomarker for predicting survival in bladder cancer.
    Zhou H; Tang K; Xiao H; Zeng J; Guan W; Guo X; Xu H; Ye Z
    J Exp Clin Cancer Res; 2015 May; 34(1):53. PubMed ID: 25991007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urinary mRNA biomarker panel for the detection of urothelial carcinoma.
    Urquidi V; Netherton M; Gomes-Giacoia E; Serie D; Eckel-Passow J; Rosser CJ; Goodison S
    Oncotarget; 2016 Jun; 7(25):38731-38740. PubMed ID: 27231851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Salivary MicroRNAs for Diagnosis of Solid Cancers.
    Kubíčková A; Slabý O
    Klin Onkol; 2018; 31(4):249-259. PubMed ID: 30541306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.